We are live on ! Find out more
AI

Atria Investments Portfolio holdings

AUM $9.98B
1-Year Est. Return 26.5%
This Fund
S&P 500
This Quarter Est. Return
+2.51%
1 Year Est. Return
+26.5%
3 Year Est. Return
+76.3%
5 Year Est. Return
+88.62%
10 Year Est. Return
+324.13%
AUM
$8.8B
AUM Growth
+$47.9M
Cap. Flow
-$77.2M
Cap. Flow %
-0.88%
Top 10 Hldgs %
14.4%
Holding
2,149
New
146
Increased
897
Reduced
969
Closed
131

Sector Composition

Rank Sector Weight
1 Technology 14.13%
2 Financials 8.3%
3 Healthcare 6.22%
4 Industrials 5.62%
5 Consumer Discretionary 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPAM icon
1101
EPAM Systems
EPAM
$5.15B
$940K 0.01%
4,589
+271
+6% +$48.3K
HYBL icon
1102
State Street Blackstone High Income ETF
HYBL
$575M
$939K 0.01%
33,019
-6,306
-16% -$179K
BUFF icon
1103
Innovator Laddered Allocation Power Buffer ETF
BUFF
$941M
$938K 0.01%
18,815
-61
-0.3% -$3.01K
PPA icon
1104
Invesco Aerospace & Defense ETF
PPA
$8.72B
$937K 0.01%
5,983
+650
+12% +$100K
FOXA icon
1105
Fox Class A
FOXA
$26.1B
$937K 0.01%
12,820
-5,472
-30% -$358K
PBH icon
1106
Prestige Consumer Healthcare
PBH
$2.54B
$936K 0.01%
15,175
-3,674
-19% -$225K
XLB icon
1107
State Street Materials Select Sector SPDR ETF
XLB
$8.72B
$936K 0.01%
20,640
-1,054
-5% -$46.6K
AER icon
1108
AerCap
AER
$23.5B
$934K 0.01%
6,499
+401
+7% +$53.1K
CCL icon
1109
Carnival Corporation Ltd
CCL
$38B
$933K 0.01%
30,562
+3,673
+14% +$102K
INFY icon
1110
Infosys
INFY
$51B
$932K 0.01%
52,318
+2,406
+5% +$41.6K
RY icon
1111
Royal Bank of Canada
RY
$292B
$930K 0.01%
5,453
+49
+0.9% +$7.53K
EWBC icon
1112
East-West Bancorp
EWBC
$18.2B
$928K 0.01%
8,260
+1,511
+22% +$160K
HUBS icon
1113
HubSpot
HUBS
$11B
$926K 0.01%
2,307
+4
+0.2% +$1.66K
ALL icon
1114
Allstate
ALL
$66.3B
$925K 0.01%
4,446
+485
+12% +$99.3K
TXT icon
1115
Textron
TXT
$15.2B
$922K 0.01%
10,572
+415
+4% +$34.7K
FEOE
1116
First Eagle Overseas Equity ETF
FEOE
$1.64B
$920K 0.01%
19,021
-389
-2% -$18.4K
FTLS icon
1117
First Trust Long/Short Equity ETF
FTLS
$2.48B
$919K 0.01%
12,942
+601
+5% +$42.5K
CYTK icon
1118
Cytokinetics
CYTK
$10.6B
$913K 0.01%
14,370
+2,223
+18% +$138K
CHE icon
1119
Chemed
CHE
$7.02B
$911K 0.01%
2,130
-1,871
-47% -$815K
HYLS icon
1120
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.64B
$910K 0.01%
21,748
+1,482
+7% +$62K
R icon
1121
Ryder
R
$9.92B
$910K 0.01%
4,756
+592
+14% +$106K
P
1122
Everpure Inc
P
$36.4B
$910K 0.01%
13,578
+2,924
+27% +$244K
NEAR icon
1123
iShares Short Maturity Bond ETF
NEAR
$4.88B
$909K 0.01%
17,790
-1,703
-9% -$87.2K
WCC
1124
WESCO International
WCC
$17.8B
$907K 0.01%
3,706
-212
-5% -$52K
MTZ icon
1125
MasTec
MTZ
$21.9B
$905K 0.01%
4,164
+476
+13% +$99.9K

Similar funds

Atria Investments's Q4 2025 Portfolio in Review

As of Q4 2025, Atria Investments held 2,149 positions worth $8.8B, up 0.55% from $8.75B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Atria Investments's Q4 2025 filing shows 146 new, 897 increased, 969 reduced and 131 closed positions. Its largest new stake was JPMorgan Core Plus Bond ETF: 238,578 shares worth $11.3M. The largest sale was iShares MSCI USA Quality Factor ETF, an estimated $23M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

  • Atria Investments's largest Q4 2025 buy was JPMorgan Core Plus Bond ETF: 238,578 shares worth $11.3M.
  • Atria Investments added most to iShares S&P 500 Value ETF in Q4 2025, an estimated $22.2M increase.
  • Atria Investments's biggest Q4 2025 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $23M.
  • Atria Investments fully exited FT Vest US Equity Buffer ETF February in Q4 2025, selling an estimated $6.19M.
  • Atria Investments's ten largest holdings make up 14% of its $8.8B portfolio in Q4 2025.
  • Atria Investments opened 146 new positions and closed 131 in Q4 2025.
  • Atria Investments's portfolio value rose 0.55% quarter-over-quarter to $8.8B.

Based on Atria Investments's 13F filing for Q4 2025, filed 5 Feb 2026.